Product information
From Health Canada
No match found
No other product was found with the same active ingredient group.
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2021-03-18
Original market date: See footnote 1
2021-03-18
Product name:
CEFTRIAXONE INJECTION, USP
DIN:
02499711
Product Monograph/Veterinary Labelling:
Date:
2025-01-16
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
BAXTER CORPORATION
7125 Mississauga Road
Mississauga
ONTARIO
CANADA
L5N 0C2
Class:
Humain
Dosage form(s):
Solution
Route(s) of administration:
Intraveineuse
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
08:12.06.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
J01DD04 (FR) CEFTRIAXONE
Active ingredient group (AIG) number:See footnote5
0117292011
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| Ceftriaxone (Ceftriaxone sodique) | 1000 MG / 50 ML |